Gotowa bibliografia na temat „RUNX2”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „RUNX2”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "RUNX2"
Pulikkan, John Anto, Xue Liting, Rachel Gerstein, Merav Socolovsky i Lucio H. Castilla. "Deletion Of Core Binding Factors Runx1 and Runx2 Leads To Perturbed Hematopoiesis In Multiple Lineages". Blood 122, nr 21 (15.11.2013): 46. http://dx.doi.org/10.1182/blood.v122.21.46.46.
Pełny tekst źródłaEstecio, Marcos R., Sirisha Maddipoti, Courtney D. DiNardo, Hui Yang, William S. Stevenson, Carlos E. Bueso-Ramos, Sherry R. Pierce, Yue Wei i Guillermo Garcia-Manero. "Association Between RUNX3 Hypermethylation and Acute Myeloid Leukemia Inv(16) Subtype". Blood 124, nr 21 (6.12.2014): 3548. http://dx.doi.org/10.1182/blood.v124.21.3548.3548.
Pełny tekst źródłaMorita, Ken, Kensho Suzuki, Shintaro Maeda, Yoshihide Mitsuda, Ayaka Yano, Yoshimi Yamada, Hiroki Kiyose i in. "Cluster Regulation of RUNX Family By "Gene Switch" Triggers a Profound Tumor Regression of Diverse Origins". Blood 128, nr 22 (2.12.2016): 443. http://dx.doi.org/10.1182/blood.v128.22.443.443.
Pełny tekst źródłaZhao, Ling, Jennifer L. Cannons, Lucio H. Castilla, Pamela L. Schwartzberg i Pu Paul Liu. "The Role of CBFβ in T Cell Development." Blood 104, nr 11 (16.11.2004): 3234. http://dx.doi.org/10.1182/blood.v104.11.3234.3234.
Pełny tekst źródłaZhao, Yangli, Tingjuan Zhang, Yangjing Zhao i Jingdong Zhou. "Distinct association of RUNX family expression with genetic alterations and clinical outcome in acute myeloid leukemia". Cancer Biomarkers 29, nr 3 (28.10.2020): 387–97. http://dx.doi.org/10.3233/cbm-200016.
Pełny tekst źródłaMaddipoti, Sirisha C., Carlos Bueso-Ramos, Hui Yang, Michael Fernandez, Shaoquing Kuang, Zihong Fang, William Stevenson, Yue Wei, Sherry Pierce i Guillermo Garcia-Manero. "Epigenetic Silencing of the RUNX3 Gene by Promoter Hypermethylation in Patients with Acute Myeloid Leukemia." Blood 112, nr 11 (16.11.2008): 3341. http://dx.doi.org/10.1182/blood.v112.11.3341.3341.
Pełny tekst źródłaCheng, Chi Keung, Libby Li, Suk Hang Cheng, Kin Mang Lau, Natalie P. H. Chan, Raymond S. M. Wong, Matthew M. K. Shing, Chi Kong Li i Margaret H. L. Ng. "Transcriptional repression of the RUNX3/AML2 gene by the t(8;21) and inv(16) fusion proteins in acute myeloid leukemia". Blood 112, nr 8 (15.10.2008): 3391–402. http://dx.doi.org/10.1182/blood-2008-02-137083.
Pełny tekst źródłade Bruijn, Marella, i Elaine Dzierzak. "Runx transcription factors in the development and function of the definitive hematopoietic system". Blood 129, nr 15 (13.04.2017): 2061–69. http://dx.doi.org/10.1182/blood-2016-12-689109.
Pełny tekst źródłaMcKillop, Anne Jane, Joanne Edwards, Emma Johnson, Susan Mason, Ewan R. Cameron i Karen Blyth. "Investigating RUNX1 and RUNX2 in prostate cancer." Journal of Clinical Oncology 35, nr 6_suppl (20.02.2017): 232. http://dx.doi.org/10.1200/jco.2017.35.6_suppl.232.
Pełny tekst źródłaWang, X. P., T. Åberg, M. J. James, D. Levanon, Y. Groner i I. Thesleff. "Runx2 (Cbfa1) Inhibits Shh Signaling in the Lower but not Upper Molars of Mouse Embryos and Prevents the Budding of Putative Successional Teeth". Journal of Dental Research 84, nr 2 (luty 2005): 138–43. http://dx.doi.org/10.1177/154405910508400206.
Pełny tekst źródłaRozprawy doktorskie na temat "RUNX2"
Yamamoto, Hiromitsu. "Runx2 and Runx3 are essential for chondrocyte maturation and Runx2 regulates limb growth through induction of Indian hedgehog". Kyoto University, 2004. http://hdl.handle.net/2433/145283.
Pełny tekst źródłaSchäfer, Henning Sebastian. "Die Untersuchung des Transkriptionsfaktors RUNX2, insbesondere die RUNX2-Cbfß Interaktion in der Pathogenese der cleidocranialen Dysplasie". [S.l. : s.n.], 2005.
Znajdź pełny tekst źródłaStephens, Alexandre, i N/A. "Genetic and Functional Characterization of RUNX2". Griffith University. School of Medical Science, 2007. http://www4.gu.edu.au:8080/adt-root/public/adt-QGU20070823.100953.
Pełny tekst źródłaStephens, Alexandre. "Genetic and Functional Characterization of RUNX2". Thesis, Griffith University, 2007. http://hdl.handle.net/10072/365677.
Pełny tekst źródłaThesis (PhD Doctorate)
Doctor of Philosophy (PhD)
School of Medical Science
Faculty of Health
Full Text
Fitzgerald, Mark. "Evidence For The Involvement Of Runx1 And Runx2 In Maintenance Of The Breast Cancer Stem Cell Phenotype". ScholarWorks @ UVM, 2018. https://scholarworks.uvm.edu/graddis/888.
Pełny tekst źródłaVega, Villa Óscar Andrés. "RUNX2 promueve la progresión tumor en osteosarcoma". Tesis, Universidad de Chile, 2011. http://repositorio.uchile.cl/handle/2250/170931.
Pełny tekst źródłaEl Osteosarcoma (OS) es el tumor sólido maligno más frecuente en la infancia y la adolescencia, corresponde al 20% de todos los tumores óseos y al 5% de los cánceres pediátricos. Los tratamientos actuales logran tasas de sobrevida a 5 años de 75% en pacientes sin metástasis, mientras que el 80% de los pacientes con enfermedad metastásica recaen a pesar del tratamiento efectuado. Runx2 es un factor de transcripción maestro que regula el proceso de diferenciación osteogénica, aunque este factor también promueve progresión tumoral en células de cáncer de próstata y de mama. Recientemente, se demostró la amplificación del gen Runx2 en pacientes con OS, así como la expresión aumentada de la proteína Runx2 en líneas celulares de OS. En esta tesis se propuso la hipótesis que el factor de transcripción Runx2 promueve migración e invasión en líneas celulares de osteosarcoma. Así, el objetivo general del proyecto fue definir el rol de Runx2 en los procesos de progresión tumoral en osteosarcoma. Para estudiar el rol de Runx2 sobre parámetros de progresión tumoral en líneas celulares de osteosarcoma, se moduló la expresión de Runx2 y se estudió su efecto en migración e invasividad. Nuestros resultados muestran que la sobreexpresión de Runx2 mediante adenovirus produjo un aumento en la capacidad de migración e invasión de líneas celulares de OS con bajos niveles de Runx2. El silenciamiento de Runx2 mediante siRNA disminuyó la capacidad de migración e invasión en líneas celulares de OS. De esta forma, hemos demostrado por primera vez que Runx2 promueve progresión tumoral en líneas celulares de OS.
Osteosarcoma (OS) is the most common malignant solid tumor in childhood and adolescence and represents 20% of all bone tumors and 5% of childhood cancers. Survival rates after five years are at 75% in patients without metastases, while 80% of patients with metastatic disease relapse despite the treatment. Runx2 is a master transcription factor that regulates the osteogenic differentiation process. However, this factor also functions as tumor promoter in prostate cancer cells and breast cancer. Runx2 gene amplification in patients with OS, as well as increased expression of Runx2 protein in OS cell line have recently been demonstrated. To this project, we hypothesized that the transcription factor Runx2 promotes migration and invasion in OS cell lines. Thus, the general aim was to define the role of Runx2 in osteosarcoma tumor progression processes. To study the role of Runx2 on parameters involved in tumor progression of OS cell lines, we modulated the expression of Runx2 and studied the outcome of this modifications on cell migration and invasiveness. Our results demonstrated that overexpression of Runx2 by adenovirus in OS cell lines with low levels of Runx2 increased cell migration and invasion. Runx2 silencing by siRNA in OS cell lines decreased their ability to migrate and invade. Thus, we have demonstrated for the first time that Runx2 promotes tumor progression in OS cell lines.
Brown, Jessie Ann. "RUNX2 in Embryonic Heart Development and Heart Disease". Thesis, The University of Arizona, 2011. http://hdl.handle.net/10150/144250.
Pełny tekst źródłaGersbach, Charles Alan. "Runx2-Genetically Engineered Skeletal Myoblasts for Bone Tissue Engineering". Diss., Georgia Institute of Technology, 2006. http://hdl.handle.net/1853/11600.
Pełny tekst źródłaPhillips, Jennifer Elizabeth. "Runx2-Genetically Engineered Dermal Fibroblasts for Orthopaedic Tissue Repair". Diss., Georgia Institute of Technology, 2007. http://hdl.handle.net/1853/19818.
Pełny tekst źródłaDoecke, James. "Genetic variation in Runx2 related to bone mineral density". Thesis, Griffith University, 2006. http://hdl.handle.net/10072/367841.
Pełny tekst źródłaThesis (PhD Doctorate)
Doctor of Philosophy (PhD)
School of Medical Science
Griffith Health
Full Text
Książki na temat "RUNX2"
Shimazu, Junko. Regulation of Runx2 Accumulation and Its Consequences. [New York, N.Y.?]: [publisher not identified], 2016.
Znajdź pełny tekst źródłaGroner, Yoram, Yoshiaki Ito, Paul Liu, James C. Neil, Nancy A. Speck i Andre van Wijnen, red. RUNX Proteins in Development and Cancer. Singapore: Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-3233-2.
Pełny tekst źródłaIto, Yoshiaki, Paul Liu i Yoram Groner. RUNX Proteins in Development and Cancer. Springer, 2017.
Znajdź pełny tekst źródłaIto, Yoshiaki, Paul Liu, Yoram Groner, James C. Neil i Nancy A. Speck. RUNX Proteins in Development and Cancer. Springer, 2017.
Znajdź pełny tekst źródłaIto, Yoshiaki, Paul Liu, Yoram Groner, James C. Neil, Nancy A. Speck i Andre van Wijnen. RUNX Proteins in Development and Cancer. Ingramcontent, 2017.
Znajdź pełny tekst źródłaIto, Yoshiaki, Paul Liu, Yoram Groner, James C. Neil, Nancy A. Speck i Andre van Wijnen. RUNX Proteins in Development and Cancer. Springer, 2018.
Znajdź pełny tekst źródłaLillard, Rossilyn. Too Scared To Run2: Loss Of Fear, Victim Turned Vigilante. CreateSpace Independent Publishing Platform, 2017.
Znajdź pełny tekst źródłaDjuretic, Ivana. Regulation of gene expression in T lymphocytes by the transcription factor Runx3. 2009.
Znajdź pełny tekst źródłaCzęści książek na temat "RUNX2"
Komori, Toshihisa. "Roles of Runx2 in Skeletal Development". W Advances in Experimental Medicine and Biology, 83–93. Singapore: Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-3233-2_6.
Pełny tekst źródłaKomori, Toshihisa. "Regulation of Osteoblast Differentiation by Runx2". W Advances in Experimental Medicine and Biology, 43–49. Boston, MA: Springer US, 2009. http://dx.doi.org/10.1007/978-1-4419-1050-9_5.
Pełny tekst źródłaBrusgard, Jessica L., i Antonino Passaniti. "RUNX2 Transcriptional Regulation in Development and Disease". W Nuclear Signaling Pathways and Targeting Transcription in Cancer, 57–86. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-8039-6_3.
Pełny tekst źródłaGreenblatt, Matthew B., Jae-Hyuck Shim, Weiguo Zou i Laurie H. Glimcher. "A Tak1/p38 Signaling Axis Regulates Runx2 Activity and Osteoblast Functions". W Osteoimmunology, 49–56. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-5366-6_6.
Pełny tekst źródłaPulica, Rachael, Karine Cohen-Solal i Ahmed Lasfar. "Evaluating the Role of RUNX2 in Cancer and Its Potential as a Therapeutic Target". W Handbook of Cancer and Immunology, 1–22. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-80962-1_254-1.
Pełny tekst źródłaShiraha, Hidenori, Shigeru Horiguchi i Hiroyuki Okada. "RUNX3". W Encyclopedia of Signaling Molecules, 4781–86. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-67199-4_101799.
Pełny tekst źródłaMoore, Amy C. "Runx1". W Encyclopedia of Cancer, 1–5. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-27841-9_5131-2.
Pełny tekst źródłaShiraha, Hidenori, Shigeru Horiguchi i Hiroyuki Okada. "RUNX3". W Encyclopedia of Signaling Molecules, 1–5. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4614-6438-9_101799-1.
Pełny tekst źródłaMoore, Amy C. "Runx1". W Encyclopedia of Cancer, 4104–9. Berlin, Heidelberg: Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/978-3-662-46875-3_5131.
Pełny tekst źródłaMoore, Amy C. "Runx1". W Encyclopedia of Cancer, 3322–26. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-16483-5_5131.
Pełny tekst źródłaStreszczenia konferencji na temat "RUNX2"
Okoli, Uzoamaka A. "Abstract PO-150: Comparison of RUNX1, RUNX2, RUNX3 and CBFβ gene expression in breast tumors Indicate ethnic differences and similarities by receptor status". W Abstracts: AACR Virtual Conference: 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; October 6-8, 2021. American Association for Cancer Research, 2022. http://dx.doi.org/10.1158/1538-7755.disp21-po-150.
Pełny tekst źródłaGnanamony, Manu, Indra Mohanam i Sanjeeva Mohanam. "Abstract 499: RUNX2 protects human neuroblastoma cells against apoptosis". W Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-499.
Pełny tekst źródłaSase, Tomohiko, Takashi Suzuki, Kou Miura, Yoshiaki Onodera, Ryuichirou Sato, Hideaki Karasawa, Akihiro Yamamura i in. "Abstract 2235: Immunohistochemical analysis of RUNX2 in human colon cancer". W Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-2235.
Pełny tekst źródłaShikata, Tetsuo, Toshihiko Shiraishi, Shin Morishita i Ryohei Takeuchi. "Effects of Acceleration Amplitude and Frequency of Mechanical Vibration on Cultured Osteoblasts". W ASME 2008 International Mechanical Engineering Congress and Exposition. ASMEDC, 2008. http://dx.doi.org/10.1115/imece2008-67221.
Pełny tekst źródłaGnanamony, Manu, Indra Mohanam i Sanjeeva Mohanam. "Abstract 5213: RUNX2 modulates the angiogenic potential of human neuroblastoma cells". W Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-5213.
Pełny tekst źródłaRoos, Alison, Jason T. Yustein i Larry Donehower. "Abstract 5036: Oncogenic role of Runx2 in the development of osteosarcoma." W Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-5036.
Pełny tekst źródłaMajid, Shahana, Hanna Nip, Altaf A. Dar, Sharanjot Saini, Varahram Shahryari, Soichiro Yamamura, Yozo Mitsui i in. "Abstract 1619: MicroRNA-466 regulates bone metastasis by targeting RUNX2 in prostate cancer". W Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-1619.
Pełny tekst źródłaXiaoying Liu i Yuguang Gao. "Runx2 is involved in regulating amelotin promoter activity and gene expression in ameloblasts". W 2013 ICME International Conference on Complex Medical Engineering (CME 2013). IEEE, 2013. http://dx.doi.org/10.1109/iccme.2013.6548218.
Pełny tekst źródłaOthman, Ahmad, Marcus Winogradzki, Manish Tandon i Jitesh Pratap. "Abstract 1240: Runx2 promotes microtubule stability for survival of breast cancer bone metastatic cells". W Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-1240.
Pełny tekst źródłaGarzón-Alvarado, D. A., i L. M. Peinado-Cortés. "Appearance and Development of Secondary Ossification Center: A Mathematical Model Approach". W ASME 2010 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2010. http://dx.doi.org/10.1115/sbc2010-19648.
Pełny tekst źródłaRaporty organizacyjne na temat "RUNX2"
Franceschi, Renny T. Epigenetic Control of Prostate Cancer Metastasis: Role of Runx2 Phosphorylation. Fort Belvoir, VA: Defense Technical Information Center, kwiecień 2013. http://dx.doi.org/10.21236/ada580104.
Pełny tekst źródłaFranceschi, Renny T. Epigenetic Control of Prostate Cancer Metastasis: Role of Runx2 Phosphorylation. Fort Belvoir, VA: Defense Technical Information Center, maj 2015. http://dx.doi.org/10.21236/ada620609.
Pełny tekst źródła